Navigation Links
LCA-Vision Announces Appointment of Edgar F. Heizer to Board of Directors
Date:2/18/2009

CINCINNATI, Feb. 18 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV) today announced that the Company's Board of Directors has elected Edgar F. (Skip) Heizer, III (age 49), as a member of the Company's Board of Directors, bringing total Board membership to six, including five independent directors.

"Skip Heizer brings LCA-Vision extensive operational, legal, corporate governance and financial expertise, as well as proven success within the multi-site healthcare services model," said E. Anthony Woods, Chairman of LCA- Vision. "We view Skip's significant real-world experience in the expansion and repositioning of healthcare businesses as directly relevant to LCA-Vision as we continue to implement measures that respond to the current economic environment and develop plans for future growth, such as our consideration of other eye-related medical and surgical procedures. We welcome Skip to our Board."

Mr. Heizer has more than 25 years of operating, investment and legal experience. He is Chairman and former Chief Executive Officer of Manus Health Systems, Inc., a multi-site dental-care provider he founded in 1997. In his various capacities at Manus, he developed strategic, operating and financing plans; led the development and implementation of financial reporting systems; led re-engineering of best practice protocols and operating systems; and managed outside legal, accounting and consulting relationships. Mr. Heizer also currently serves as Principal of Coral SR LLC / Heizer Capital, a management and investment firm focused on growth businesses in transition that he founded in 1995. Among numerous assignments, he has served as a senior advisor to companies in the specialty surgery and disease management business. Mr. Heizer previously was partner at the full-service law firm Gardner, Carton & Douglas. During his tenure, he served as general corporate counsel to healthcare companies, including several with multi-site models.

In addition to serving as Chairman of Manus Health Systems, Mr. Heizer is a member of the board of three private companies, including Dental Services Group, a national operator of dental laboratories. He is member of the Investment Advisory Board of venture capital firm Seneca Health Partners and a member of the National Association of Corporate Directors. He received a Juris Doctorate from Northwestern University School of Law and Bachelor of Science in Engineering and Bachelor of Business Administration from Southern Methodist University.

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 75 LasikPlus(R) fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

    Earning Trust Every Moment.

    Transforming Lives Every Day.

    For Additional Information

    Company Contact:                    Investor Relations Contact:
    Barb Kise                           Jody Cain
    LCA-Vision Inc.                     Lippert/Heilshorn & Associates
    513-792-9292                        310-691-7100

'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LCA-Vision Announces Consent Solicitation Deadline; Urges Stockholders to Return Gold Consent Revocation Card
2. LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results
3. LCA-Visions National Lasik Network Named as U.S. Provider for National Vision Administrators
4. The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders
5. LCA-Vision to Hold Corporate Update Conference Call and Q&A Session on February 6
6. LCA-Vision to Announce Fourth Quarter and Full Year 2008 Financial Results on Tuesday, February 10, 2009
7. The LCA-Vision Full Value Committee Files Preliminary Consent Solicitation Statement to Reconstitute the Board of Directors of LCA-Vision Inc.
8. LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Groups Threatened Consent Solicitation
9. LCA-Visions Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders
10. LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group
11. LCA-Visions Former Executive Management Urge Board of Directors to Immediately Call Special Shareholder Meeting to Approve Poison Pill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company ... and full year ended December 31, 2015 on Monday, February 29, 2016 after the ... investment community following the release at 4:30 PM ET. Investors interested in participating by ...
(Date:2/10/2016)... Boston, Massachusetts (PRWEB) , ... February 10, 2016 ... ... practice models to effectively measure change in their patients. Research shows that the ... traditional methods. To help therapists overcome this challenge and learn more about the ...
(Date:2/10/2016)... Palm Beach, Florida (PRWEB) , ... February 10, ... ... & Country Club) announced that it has been awarded the prestigious Distinguished Emerald ... the World award program conducted by BoardRoom magazine, one of the most respected ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... 1 UNF Drive, Jacksonville, FL 32224, February 26th: Amateur & Professional Divisions ... Division - Time: 7:00pm – 10:00pm | Ticket Prices $30, Social Media: ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of ... in the state still face a lot of restrictions as to where they can ... for private, personal use” and that cannabis “may not be consumed openly or publicly.” ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... February 10, 2016 --> ... (Liquid & Gas), and Spectroscopy Market by Industry (Oil & ... Pulp & Paper, Metal & Mining, and Others), And ... the global market is expected to grow to USD ... 8.6% between 2015 and 2020. Browse 82 ...
(Date:2/10/2016)... , Feb. 10, 2016 CSI Specialty ... with the launch of the Specialty Pharmacy Podcast. A ... industry-first, aimed at providing real-world education, discussion and context ... --> --> The Specialty ... CEO of CSI Specialty Group Suzette DiMascio, CHE, CMCE, ...
(Date:2/10/2016)... SAN DIEGO , Feb. 10, 2016 ... leader in viral gene therapy manufacturing, and Renova™ Therapeutics, ... heart failure and other chronic diseases, have entered into ... process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for ... --> --> This relationship will ...
Breaking Medicine Technology: